Evidence map›Paper›PMID 7865982›Full record

Trial reportThe Clinical investigator1994

Low-dose hydrocortisone infusion attenuates the systemic inflammatory response syndrome. The Phospholipase A2 Study Group.

J Briegel, W Kellermann, H Forst, M Haller, M Bittl, G E Hoffmann, M Büchler, W Uhl, K Peter

Registry-linked trialAbstract readClinical TrialMulticenter Study
PubMed Publisher
In one paragraph

Trial report in The Clinical investigator, 1994. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00732277 (Evaluation of Corticosteroid Therapy in Childhood Severe Sepsis), which is not on this map. Cited by 30 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 3 pooled it
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00732277 phase2completednot on this mapstarted 2008, after this paper: background citation

Evaluation of Corticosteroid Therapy in Childhood Severe Sepsis (Steroids in Paediatric Sepsis, StePS) - a Randomised Pilot Study

TypeinterventionalSponsorUniversity Hospital Southampton NHS Foundation TrustRan2008 to 2012Enrolled21ConditionsSepsisArmshydrocortisone
3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 3 syntheses or guidelines pooled it, 155 citations in OpenAlex.

  1. Corticosteroids for treating sepsis in children and adults.The Cochrane database of systematic reviews · 2025
    Pooled it
  2. Corticosteroids for treating sepsis in children and adults.The Cochrane database of systematic reviews · 2019
    Pooled it
  3. Corticosteroids for treating sepsis.The Cochrane database of systematic reviews · 2015
    Pooled it
  4. Effects of single dose of dexamethasone on patients with systemic inflammatory response.Sao Paulo medical journal = Revista paulista de medicina · 2006
    Trial
  5. Trial
  6. Review
  7. Immune Effects of Corticosteroids in Sepsis.Frontiers in immunology · 2018
    Review
  8. Article
  9. Protective effect of phosphatidylcholine on lipopolysaccharide-induced acute inflammation in multiple organ injury.The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology · 2013
    Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Relative adrenal insufficiency in the preterm and term infant.Journal of perinatology : official journal of the California Perinatal Association · 2009
    Review
  16. Review
  17. Article
  18. The hypothalamic-pituitary-adrenal axis in critical illness.Reviews in endocrine & metabolic disorders · 2007
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

J BriegelInstitut für Anaesthesiologie, Ludwig-Maximilians-Universität München, Klinikum Grosshadern, Germany.
W Kellermann
H Forst
M Haller
M Bittl
G E Hoffmann
M Büchler
W Uhl
K Peter
Ludwig-Maximilians-Universität München · DEMünchen Klinik · DEMünchen Klinik Bogenhausen · DEUniversität Ulm · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

There is increasing evidence that the hypercortisolemia in inflammatory diseases suppresses the elaboration of proinflammatory cytokines, thus protecting the host from its own defence reactions. In severe sepsis and septic shock cortisol levels are usually elevated, but some patients may have relative adrenal insufficiency. This may contribute to the overwhelming systemic inflammatory response syndrome. We evaluated the impact of low-dose hydrocortisone infusion (10 mg/h) on the course of the systemic inflammatory response syndrome. This dose corresponds to a maximum secretory rate of cortisol achieved in corticotropin-stimulated healthy humans. In a prospective observational study 57 surgical patients with severe sepsis or septic shock were studied, of which in addition to the conventional treatment 12 patients were infused with low-dose hydrocortisone, and 45 were treated without any corticosteroid. In the longitudinal analysis the systemic inflammatory response--as judged by body temperature, cardiovascular response, and kinetics of inflammatory mediators such as phospholipase A2, C-reactive protein, and neutrophil elastase--started to differ in favor of the hydrocortisone-treated patients after 2 days of treatment (P < 0.05, Mann-Whitney U test). The difference disappeared after withdrawal of exogenous cortisol. Shock reversal was achieved in all patients treated with low-dose hydrocortisone. The data provide evidence that low-dose hydrocortisone infusion attenuates the systemic inflammatory response in human septic shock. From an immunological point of view a relative cortisol deficiency may contribute to the amplified immune response in systemic inflammatory diseases. A randomized clinical trial must clarify the impact of low-dose hydrocortisone infusion on the clinical course and outcome of septic shock patients.

Indexed as

Adrenal InsufficiencyAdultAgedBiomarkersCohort StudiesCombined Modality TherapyFemaleFeverHemodynamicsHumansHydrocortisoneInflammationMaleMiddle AgedMultiple Organ FailureProspective StudiesBiomarkersHydrocortisone

Identifiers

PMID7865982
OpenAlexW2012730520

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.